Literature DB >> 42597

Clinical investigation of serum deoxyribonuclease: I. Analysis of serum deoxyribonuclease activity in comparison with normal and after endoscopic retrograde pancreatography.

A Funakoshi, T Kimura, H Wakasugi, H Ibayashi.   

Abstract

Serum Deoxyribonuclease (DNase) micro-assay method was developed using 32P-labelled E. coli DNA as substrate. The serum DNase showed maximum activity at pH 7.5. It required Mg+ for activity, and was inhibited by EDTA or EGTA. The enzyme was also inhibited by actin (60-65%) or bovine pancreatic DNase I antibody (40-45%). The serum DNase activity was markedly increased following endoscopic retrograde pancreatography (ERP) examination. These results imply that serum DNase activity is mostly at least 60-65% pancreatic DNase I.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 42597     DOI: 10.1007/bf02773730

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  14 in total

1.  Nucleases and their inhibitors in the cellular components of human blood.

Authors:  S GUPTA; R M HERRIOTT
Journal:  Arch Biochem Biophys       Date:  1963-04       Impact factor: 4.013

2.  Desoxyribonuclease I activity in pancreatic disease.

Authors:  O D KOWLESSAR; R K MCEVOY
Journal:  J Clin Invest       Date:  1956-12       Impact factor: 14.808

3.  Presence of two different desoxyribonucleode-polymerases in veal kidney.

Authors:  L CUNNINGHAM; M LASKOWSKI
Journal:  Biochim Biophys Acta       Date:  1953-08

4.  Purification from calf thymus of an inhibitor of deoxyribonuclease I.

Authors:  M U Lindberg; L Skoog
Journal:  Eur J Biochem       Date:  1970-04

5.  A deoxyribonuclease which requires nucleoside triphosphate from Micrococcus lysodeikticus. I. Purification and characterization of the deoxyribonuclease activity.

Authors:  M Anai; T Hirahashi; Y Takagi
Journal:  J Biol Chem       Date:  1970-02-25       Impact factor: 5.157

6.  Some aspects of the desoxyribonuclease activities of animal tissues.

Authors:  V ALLFREY; A E MIRSKY
Journal:  J Gen Physiol       Date:  1952-11       Impact factor: 4.086

7.  Purification and properties of human pancreatic deoxyribonuclease I.

Authors:  A Funakoshi; Y Tsubota; H Wakasugi; H Ibayashi; Y Takagi
Journal:  J Biochem       Date:  1977-12       Impact factor: 3.387

8.  Deoxyribonuclease IV: a new exonuclease from mammalian tissues.

Authors:  T Lindahl; J A Gally; G M Edelman
Journal:  Proc Natl Acad Sci U S A       Date:  1969-02       Impact factor: 11.205

9.  Actin is the naturally occurring inhibitor of deoxyribonuclease I.

Authors:  E Lazarides; U Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  1974-12       Impact factor: 11.205

10.  Crystalline desoxyribonuclease; isolation and general properties; spectrophotometric method for the measurement of desoxyribonuclease activity.

Authors:  M KUNITZ
Journal:  J Gen Physiol       Date:  1950-03       Impact factor: 4.086

View more
  1 in total

1.  Clinical investigation of serum deoxyribonuclease: II. Clinical studies of serum deoxyribonuclease activity in pancreatic disease.

Authors:  A Funakoshi; H Wakasugi; H Ibayashi
Journal:  Gastroenterol Jpn       Date:  1979-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.